Bibliografia

Vai a Menu Iniziale

Perfusioni d’Arto per Melanoma

 

  1. Cavaliere, F. Di Filippo, F. Cavaliere, et al.
    Clinical Practice of Hyperthermic Extremity Perfusion in Combination with Radiotherapy and Chemotherapy.
    Medical Radiology, Thermoradiotherapy and Termochemotherapy, Ed. by M.H. Seegenschmiedt Springer-Verlag, 1996; 2: 323-345.
  2. Krementz ET
    Regional perfusion. Current sophistication, what next?
    Cancer, 57: 416, 1986.
  3. H.Schraffordt Koops, B.B.R. Kroon, F.J. Lejeune
    Management of Local Recurrence, satellites and in Transit Metastases of the Limbs with Isolation Perfusion
    In "Malignant Melanoma" Ed F.J. Lejeune Pub McGraw-Hill 1994 Pag. 221-231
  4. Hahn GC
    Hyperthermia and cancer. Plenum Press, New York, 1982
  5. M. McBride, M. J. McMurtrey, E. M. Copeland and R. C. Hickey.
    Regional Chemotherapy by Isolation-Perfusion.
    International Advances in Surgical Oncology, 1978; 1: 1-9.
  6. P.Autier
    Epidemiology of Melanoma
    In "Malignant Melanoma" Ed F.J. Lejeune Pub McGraw-Hill 1994 Pag. 1-7
  7. D.L. Fraker, D.G. Coit
    Isolated perfusion of Extremity Tumor
    In "Regional Therapy of Advanced Cancer" Ed.M.T.Lotze Pub. Lippincott-Raven Philadelphia1997 pag333-349
  8. Cavaliere, F. Di Filippo, F. Cavaliere, et al.
    Clinical Practice of Hyperthermic Extremity Perfusion in Combination with Radiotherapy and Chemotherapy.
    In "Medical Radiology, Thermoradiotherapy and Termochemotherapy," Ed. by M.H. Seegenschmiedt Springer-Verlag, 1996; 2: 323-345.
  9. Clark, A. J. Grabs, P. G. Parsons, et al.
    Melphalan Uptake, Hyperthermic Synergism and Drug Resistance in a Human Cell Culture Model for the Isolated Limb Perfusion of Melanoma.
    Melanoma Res., 1994; 4(6): 365-370.
  10. Di Filippo, A. Calabro', D. Giannarelli, et al.
    Prognostic Variables in Recurrent Limb Melanoma Treated with Hyperthermic Antiblastic Perfusion.
    Cancer,1989; 63: 2551-2561.
  11. J. Bowers and E. M. Copeland.
    Surgical Limb Perfusion for Extremity Melanoma.
    Surgical Oncology, 1994; 3: 91-102.
  12. M. Klaase, B. B. R. Kroon, B. N. van Geel, et al.
    Patient- and Treatment-Related Factors Associated with Acute Regional Toxicity after Isolated Perfusion for Melanoma of the Extremities.
    The American Journal of Surgery, 1994; 167: 618-620.
  13. M. Urist.
    The Role of Surgery in the Management of Advanced Melanoma.
    In: Therapy of Advanced Melanoma
    (Ed. P. Rumke, Amsterdam - Karger), 1990; pag. 1-13.
  14. J. Bryant, G. A. Balderson, P. Mead, W. S. Egerton.
    Hyperthermic Isolated Limb Perfusion for Malignant Melanoma: Response and Survival.
    World J. Surg., 1995; 19: 363-368.
  15. G. Coit.
    Isolation Limb Perfusion for Melanoma: Current Trends and Future Directions.
    Melanoma Research, 1994; 4: 57-60.
  16. Hafstrom L,Rudenstam C. M. , Blomquist E. et al.
    Regional Hyperthermic perfusion with Melphalan after surgery for recurrent melanoma of the extremities
    J.Clin.Oncol,1991 ;9 :2091-2094.
  17. Ghussen, I. Kruger, R. V. Smalley and W. Groth.
    Hyperthermic Perfusion with Chemotherapy for Melanoma of the Extremities.
    World J. Surg.,1989; 13: 598-602.
  18. A.Brobeil,C.Berman,CW Cruise,R. De Conti, N.Fenske, F. Glass,J.Messina, D.Rappaport, K.Wells, D.Reintgen
    Survival advantage for Patients With Extremity Confined Recurrent Melanoma with Hyperthermic Isolated Limb Perfusion
    Ann.surg.Oncol., 1998,5:376-383
  19. F.Lejeune, D. Lienard
    Isolation Perfusion of the Limbs for In Transit Melanoma Metastases with Cytokines and Chemotherapy
    In "Malignant Melanoma" Ed F.J. Lejeune Pub McGraw-Hill 1994 Pag. 233-240
  20. D. Lienard,A.M.M. Eggermont, H Schraffordt Koops, B.B.R. Kroon, F. RosenKaimer, P.Autier, F.J.Lejeune
    Isolated perfusion of the limb with High dose TNF,IFN and Melphalan for Melanoma Stage III. Results of a Multi-centre pilot study
    Mel Res. 1994,4(Suppl 1) :21-26
  21. D. Barlett,H. Alexander, S.Libutti,D.Fraker
    Isolated Limb perfusion with TNF and Melphalan in Patients with Extremity Melanoma after failure of Isolated Limb Perfusion with Chemotherapeutic
    Cancer,1997,1:2084-90
  22. Schraffordt Koops.
    Surgical Quality Control in an International Randomized Clinical Trial.
    European Journal of Surgical Oncology, 1992; 18: 525-529.
  23. D. Lienard, F.Lejeune,P.Autier,F.Sales,G.Ghanem
    Physiological and Pharmacokinetics Parameters in Isolation Perfusion of the Limbs
    In In "Malignant Melanoma" Ed F.J. Lejeune Pub McGraw-Hill 1994 Pag. 241-248
  24. Hyperthermic antiblastic extracorporeal circulation :anesthesiologic considerations
    M.Aimone Secat, M.De Simone,G. Izzo, G. Fagiano
    Panminerva Med.,38-Suppl. 1 to 2 :12-14,1996
  25. Hyperthermic antiblastic perfusion : technical problems
    G. Izzo, M.De Simone, M.Aimone Secat, ,R.Barone
    Panminerva Med.,38-Suppl. 1 to 2 :15-17,1996
  26. Hyperthermic antiblastic perfusion of the extremities,the pelvic cavity and the peritoneum.Surgical techniques and methods.Initial Clinical experience.
    M.De Simone,,M.Aimone Secat,G. Izzo, R.Barone, F.Patanč, M.Bacega, M.Giaccone, P.Cesana, G.Fagiano, P.Polacchi,F. Moffa, M. Dei Poli
    Panminerva Med.,38-Suppl. 1 to 2 :28-34,1996
  27. Use of 99mTc microcolloid in the blood leakage monitoring during hyperthermic isolated limb perfusion
    M.Bacega ,P.Cesana ,R. Ropolo M.De Simone, M.Aimone Secat,G. Izzo, R.Barone.,
    Panminerva Med.,38-Suppl. 1 to 2 :51-52,1996

 

Perfusioni d’Arto per SARCOMA

  1. 1. Simon HA, Enneking WF :"The management of soft tissue sarcomas of the extremities". J Bone Joint Surg. 1976, 58A: 317-27.

    2. Liebel S.A: "Soft tissue sarcomas: therapeutic results ad rationale for conservative surgery and radiation therapy". In: radiation Oncology Annual, Phillps TC, Pistumac DA eds. 1983.

    3. Azzarelli A, et al.: "Intraarterial induction chemotherapy for soft tissue sarcomas" Proceedings of International Meeting Osteosarcoma and Adult Soft Tissue Sarcomas: Present Trends, 74-77, 1991.

    4. Eilber FR, Micra J, Eckardt J, et al: "Intra-arterial Adriamycin, radiation therapy and surgical excision for extremity skeletal and soft tissue sarcomas. Dev Oncol 26:141-152, 1984

    5. Didolkar MS, Kanter PM, Baffi RR e coll: "Comparison of regional versus systemic chemotherapy with Adriamycin". Ann Surg 187: 332,1978.

    6. Mc Bride CM, Mc Murtrey MJ, Copeland EM, Hickey RC: "Regional Chemotherapy by isolation perfusion". Int Advances Surg Oncol 1978; 1: 1-9.

    7. Stehlin JS, et al :"15 year's experience with hyperthermic perfusion for treatment of soft tissue sarcoma and malignant melanoma of the extremities. In :Vaeth JM (ed) Hyperthermia and radiation therapy/chemotherapy in the treatment of cancer. San Francisco, 1984, pp 177-182.

    8. Lehti PM, et al :" Improved survival for soft tissue sarcoma of the extremities by regional hyperthermic perfusion, local excision and radiation therapy". Surg Gynecol Obstet 162:149-152, 1986.

    9. Krementz ET: Regional perfusion. Current sophistication, what next? Cancer 57: 416-432, 1986.

    10. Hoekstra HJ, Schraffordt Koops H, Oldhohh J :"Results of isolated regional perfusion in the treatment of malignant soft tissue tumors of the extremities" Cancer 1987; 60: 1703-7.

    11. Di Filippo F, Calabrņ A, Cavallari A, Carlini S, Buttini GL, Moscarelli F, Cavaliere F, Piarulli L, Cavaliere R. The role of hyperthermic perfusion as a first step in the treatment of soft tissue sarcoma of the extremities. World J Surg 12:333-339, 1988

    12. Di Filippo F, Giannarelli D, Botti C, Carlini S, Cavaliere F, Schiratti M, Casaldi V, Tedesco M, and Cavaliere R. Hyperthermic antiblastic perfusion for the treatment of soft tissue sarcoma. Ann Oncol 3(1):71-74, 1992.

    13. Fi Filippo F, Botti C, Giannarelli D, Carlini S, Cavaliere F, and Cavaliere R. Thermochemotherapy for soft tissue sarcomas. In: Soft Tissue Sarcomas: New Developments in Multidisciplinary Approach to Treatment. Pinedo HM, Verweij J, and Suit HD (Eds) Kluwer Academic Publischers, Boston, 127-147, 1991.

    14. Lienard D, Lejeune FJ, Eweluko P: "In transit metastases of malignant melanoma treated by high base r-TNF-alpha on combination with interferon gamma and melphalan in isolation perfusion. Wr J Surg, 1991.

    15. Lienard D, Ewalenko P, Delmatte J, Renard N, Lejeune FJ:"High dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma." J Clin Oncol 1992; 10: 52-60.

    16. Hill S, Fawcett WJ, Sheldon J, etc:"Low-dose tumour necrosis factor alpha and melphalan in hyperthermic isolated limb perfusion". Br J Surg 1993, Vol 80, 995-997.

    17. Di Filippo F, Calabrņ AM, Giannarelli D, Carlini S, Cavaliere F, Moscarell F, and Cavaliere R: Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. Cancer 63:12, 2551-2561, 1989.

    18. Vaglini M. Techinique for regional perfusion. Am J Extr Techn 18:12-20, 1986.

    19. Ghussen F, et al:"Hyperthermic perfusion with chemotherapy in melanoma of the extremities". World J Surg, 1989, 13:598.

    20. Carter SK,:"Clinical trials in cancer chemotherapy" Cancer,1977,40: 544-57.

    21. Hansen HH:"Clinical experience with 1-(2-chloroethyl)3-cycloexyl-1-nitronausea (CCNU, NSC 79037). Proc Am Ass Cancer Res 1970,11:43.

    22. Gottlieb JA."Phase I and phase II clinical trials : a critical reappraisal". In: the Pharmacologic basis of cancer chemotherapy. Williams and Wilkens, Baltimore, 1974.

    23. Williams DJ and Carter SK. "Management of trials in the development of cancer, 1978,37: 434-437.

    24. Watanabe N, Niitsu Y, Umeno H, Sone H, Neda H, Uamauchi N, et al. "Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia". Cancer Res 1988, 48:650.

    25. Niitsu Y, Watanabe N, Umeno H, Sone H, Neda H, Yamauchi N, et al. "Synergistic effects of ecombinant human tumor necrosis factor and hyperthermia on in vitro cytotocixity and artificial metastases". Cancer Res 1988, 48:654.

    26. Srinivason JM, Fajardo LF, Hahn GM. "Mechanism of antitumor activity of tumor necrosis factor alpha with hyperthermia in tumor necrosis factor alpha-resistant tumor". Journal of the NCI 1990, 82:1904-1910.

  1. Maeda T, et al. "Hyperthermic enhancement of antitumor effect of natural human tumor necrosis factor alpha and beta: an in vitro and in vivo study". Jpn J Cancer Res, 1988, 79:1054-1061.
  1. R. Rossi, A. Vecchiato, M. Foletto, et al.
    Phase II Study on Neoadjuvant Hyperthermic-Antiblastic Perfusion with Doxorubicin in Patients with Intermediate or High Grade Limb Sarcomas.
    Cancer, 1994; 73: 2140-2146.
  2. J. Lejeune, D. Lienard and P. Ewalenko.
    Hyperthermic Isolation Perfusion of the Limbs with Cytostatics after Surgical Excision of Sarcomas.
    World J. Surg., 1988; 12: 345-348.
  3. Lebredo l., Wolthering H., Moseley S., Bos G., Small K.,
    Results of Cisplatin Hyperthermic Isolation Perfusion with dose escalation for extremity sarcomas.
    Reg. Cancer Treat.,1988, 2:120-124
  4. D. Lienard, F.Lejeune,P.Autier,F.Sales,G.Ghanem
    Physiological and Pharmacokinetics Parameters in Isolation Perfusion of the Limbs
    In In "Malignant Melanoma" Ed F.J. Lejeune Pub McGraw-Hill 1994 Pag. 241-248
  5. Hyperthermic antiblastic extracorporeal circulation :anesthesiologic considerations
    M.Aimone Secat, M.De Simone,G. Izzo, G. Fagiano
    Panminerva Med.,38-Suppl. 1 to 2 :12-14,1996
  6. Hyperthermic antiblastic perfusion : technical problems
    G. Izzo, M.De Simone, M.Aimone Secat, ,R.Barone
    Panminerva Med.,38-Suppl. 1 to 2 :15-17,1996
  7. Hyperthermic antiblastic perfusion of the extremities,the pelvic cavity and the peritoneum.Surgical techniques and methods.Initial Clinical experience.
    M.De Simone,,M.Aimone Secat,G. Izzo, R.Barone, F.Patanč, M.Bacega, M.Giaccone, P.Cesana, G.Fagiano, P.Polacchi,F. Moffa, M. Dei Poli
    Panminerva Med.,38-Suppl. 1 to 2 :28-34,1996
  8. Use of 99mTc microcolloid in the blood leakage monitoring during hyperthermic isolated limb perfusion
    M.Bacega ,P.Cesana ,R. Ropolo M.De Simone, M.Aimone Secat,G. Izzo, R.Barone.,
    Panminerva Med.,38-Suppl. 1 to 2 :51-52,1996

PERFUSIONI PERITONEALI

  1. Averbach A.M., Sugarbaker P.H.
    Methodologic considerations in treatment using intraperitoneal chemotherapy.
    In Peritoneal carcinomatosis:Principles of Management Boston:Kluwer Academic Publisher,1996:289-309
  2. Averbach A.M., Sugarbaker P.H.
    Peritoneal Mesothelioma:treatment approach based on natural history
    In Peritoneal carcinomatosis:Principles of Management Boston:Kluwer Academic Publisher,1996:193-211
  3. Barlogie B. et al
    In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum and Mitomycin C
    Cancer Res 40:1165,1980
  4. Bowers J. and E. M. Copeland.
    Surgical Limb Perfusion for Extremity Melanoma.
    Surgical Oncology, 1994; 3: 91-102.
  5. De Simone M., Aimone M., Izzo G., Ghezzo F., Grosso M., Livigni S., Nano M., Suppo M., Barone R.and Dei Poli M.
    Peritonectomy and Hyperthermic Antiblastic Peritoneal Perfusion (HAP) for Peritoneal Carcinomatosis
    J.Exp.Clin.Cancer Res.,16 (2) :356-357,1997
  6. De Simone M., Aimone Secat M. , Izzo G., Barone R., Patanč F., Bacega M., Giaccone M., Cesana P., Fagiano G., Polacchi P., Moffa F., Dei Poli M.
    Hyperthermic antiblastic perfusion of the extremities,the pelvic cavity and the peritoneum.Surgical techniques and methods.Initial Clinical experience.
    Panminerva Med.,38-Suppl. 1 to 2 :28-34,1996
  7. Dickinson J.A.
    Hyperthermia and laboratory animal system
    In Proc.Intnl.Symp. by Hyperthermia and radiation on Cancer Ther. Whashingtopn D.C. April 1975, Am.Coll.Rad. 105-106
  8. Dziambor H., Hager E.D.
    Intraperitoneal Hyperthermic Perfusion Chemotherapy of Patients with Peritoneal Disseminated Drug Resistence Ovarian Cancer
    Onkologie, 1997,29:33
  9. Elias D., Damia E., et a.l
    Thermic homogeneity and standardization of intraperitoneal chemohyperthermia for peritoneal carcinomatosis
    Reg. Cancer Treat., 1996,9:54-59
  10. Fujimoto M., Takahashi T., Mutou S., et al.
    Clinical Outcome of Intraperitoneal Hyperthermic Perfusion (IPHP) for Peritoneal Carcinomatosis from Gastric Cancer.
    Abstr. VII° Int. Congress Reg. Cancer Treat.
    (Sept. 11-13-1995, Wiesbaden - Germany), pag. 55.
  11. Gilly F.,Sayag-Beaujard A.C.,Carry P.Y. et al Gilly F., P. Y. Carry, A. C. Sayag, et al.
    Intraperitoneal Chemo-Hyperthermia in the treatment of Peritoneal Carcinomatosis from digestive origin.
    Panminerva Med.,38-Suppl. 1 to 2 :46-47,1996
  12. Hahn GC
    Hyperthermia and cancer. Plenum Press, New York, 1982.
  13. Jacquet A. M. , Averbach A., Stephens D., Sugarbaker P. H.
    Cancer Recurrence Following Laparoscopic Colectomy: Report of Two Patients Treated with Heated Intraperitoneal Chemotherapy.
    Dis. Colon Rectum,1995; 38: 1110-1114.
  14. Koga S., Hamazoe R., Maeta M. et al.
    Prophylactic therapy for peritoneal recurrence of gastric cancer by continuos hyperthermic peritoneal perfusion with mitomycin c.
    Cancer,1988,61 :232
  15. Loggie W., and Fleming R. A.
    Intraperitoneal Heated Chemotherapy for Peritoneal Carcinomatosis.
    Abstr. VII° Int. Congress Reg. Cancer Treat.
    (Sept. 11-13-1995, Wiesbaden - Germany), pag. 41.
  16. Ma G., Barlett D., Figg w., Lush R., Lee K., Libutti S.,Alexander H.
    Continuous Hyperthermic peritoneal perfusion with cisplatin for for the treatment of peritoneal mesothelioma
    Cancer j. Sci. Am.,1997,3:174-179
  17. Rossi R., Deraco M., Vaglini M., et al.
    Carcinosi Peritoneale: Razionale e Indicazioni al Trattamento Chirurgico Associato alla chemioterapia intraperitoneale.
    Argomenti di Oncologia, 1995; 16: 307-311.
  18. Shimizu T.,Maeta M.,Koga S.,
    Influence of local Hyperthermia on the healing of small intestinal anastomoses in rat.
    Br.J.Surg,1991,78:57-59
  19. Sugarbaker P.H.
    Intraperitoneal Chemotherapy and Cytoreductive Surgery
    Ed. Ludann Company,Grand Raoids-Michigan. Oct.1995
  20. Sugarbaker P.H.
    Peritonectomy Procedures.
    Ann. Surg., 1995; 221: 29-42.
  21. Sugarbakrer P.H., Schellinx E.T.,Chang D. et al
    peritoneal Carcinomatosis from adenocarcinoma of Colon
    World J.Surg, 20 :582-595,1996
  22. Takahashi S., Fujimoto S., Kobayashi K., et al.
    Clinical Outcome of Intraoperative Pelvic Hyperthermochemotherapy for Patients with Dukes'C Rectal Cancer.
    Int. J. Hyperthermia, 1994; 10: 749-750.
  23. Yamaguchi Y, Tsukioka Y., Fushida S., et al.
    Intraperitoneal Hyperthermic Treatment for Peritoneal Dissemination of Colorectal Cancers.
    Dis. Colon Rectum, 1992; 35: 964-968.
  24. Yonemura Y, Ninomiya I., Kaji M., et al.
    Prophylaxis with Intraoperative Chemohyperthermia Against Peritoneal Recurrence of Serosal Invasion-Positive Gastric Cancer.
    World J. Surg.,1995; 19(3): 450-455.
  25. Yonemura Y.,Fujimura T.,Fushida S et al.
    Intraperitoneal Hyperthermochemotherapy cobined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination
    World J. Surg.,1991 ;15 :530
  26. Yonemura Y.,Fujimura T.,Nishimura G. et al.
    Effect of Intraoperative chemohypertermia in patients with gastric cancer with peritoneal dissemination
    Surgery,119 :437-444,1996
  27. Zwelling L.A. et Al
    DNA-protein and DNA interstrand cross-linking by cis and trans-platinum in L1210 mouse leukemia cells and relation to cytotoxicity
    Cancer. Res. 39:365,1979
  28. Lederman Gs., Recht A., Herman T.
    Long-term survival in peritoneal mesothelioma: The role of radiotherapy and combined modality treatment.
    Cancer 59.1882-1886, 1987
  29. Vermorken J.B., Pecorelli S.
    Clinical Trials in patients with epithelial ovarian cancer:past, present and future
    Eur. J. Surg. Oncol, 22:455-466,1996
  30. Van Der Burg ML, Van Lent M.,Buyse M. et al
    The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer
    N. Eng. J. Med. ,332:629-634,1995
  31. Sugarbaker P.H., Ronnett B.M., Archer A. et al
    Pseudomixoma Peritonei Syndrome
    Advances in Surg. ,30:233-280,1997
  32. Yonemura Y., Fujimura T.,Fushida S., et al.
    Hyperthermo-chemotherapy for treatment of Peritoneal Carcinomatosis
    da Yonemura y. (ed)Peritoneal Dissemination , Ed. Maeda Shoten –Kanazawa pag 237-260, 1998.
  33. Nishimura G.,Yonemura Y.,Fujimura T.
    Intraperitoneal Treatment for Peritoneal Dissemination from Colorectal Cancer
    daYonemura y. (ed) Peritoneal Dissemination , Ed. Maeda Shoten –Kanazawa pag 261-265, 1998
  34. Fujimoto S.,Takahashi M.,Kobayashi K., et al
    Heated Intraperitoneal mitomycin C infusion treatment for patients with gastric cancer and peritoneal metastasis
    da P.Sugarbaker (ed) Peritoneal Carcinomatosis:Drugs and Diseases Ed. Kuwler, Bosron
    pag 239 –245,1996
  35. Salle B.,Gilly F.N., Carry A.
    Chimio-hyperthermie intraperitoneale dans le traitement des carcinoses peritoneales d’origine ovarienne
    J.Gynecol.Obst.Biol.Reprod., 22:369-371,1993

Vai a Menu Iniziale